TAG:
pathology consultants
AmeriPath Pursues Ambitious Strategy Of Rapid Expansion
By Robert Michel | From the Volume VII No. 4 – March 6, 2000 Issue
CEO SUMMARY: As the pathology profession’s only publicly-traded physician practice management company, AmeriPath is the spear point of far-reaching changes now transforming pathology. With an annual revenue run rate of $270 million and an ample war chest of growth capital, AmeriPath int…
Single-Specialty Path PPMs Posting Strong Growth, Profits
By Robert Michel | From the Volume VII No. 3 – February 14, 2000 Issue
CEO SUMMARY: Although the financial travails of the physician practice management (PPM) industry are widely known, there is little recognition that a number of single-specialty PPMs are doing well. This is true of pathology, where at least six pathology-based PPMs still remain in business…
Pathology Profession Facing New Directions
By Robert Michel | From the Volume VII No. 2 – January 24, 2000 Issue
CEO SUMMARY: Big changes ahead during the next decade. Among the predictions: the number of two and three-pathologist group practices will radically diminish; pathology centers of excellence will achieve new market dominance; and…ever more intense competition for anatomic pathology spec…
“December 13, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 17 – December 13, 1999 Issue
Pathology Consultants of America, Inc. announced a promotion and a new hire. Bill McDowell was promoted to Vice President and Chief Development Officer. The new member to PCA’s management team is Edward D. Dooling. Dooling will be Vice President of Sales, Marketing and Managed Care…
“November 22, 1999 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume VI No. 16 – November 22, 1999 Issue
UroCor, Inc. of Oklahoma City, Oklahoma is losing its long-time Chairman and CEO. Effective December 31, 1999, William A. Hagstrom will leave the company to pursue “new business start-up activities.” Hagstrom joined UroCor back in 1989, and helped it emerge from a Chapter 11 bank…
DARK REPORT Picks 1998’s Ten Biggest Lab Stories
By Robert Michel | From the Volume VI No. 1 – January 11, 1999 Issue
CEO SUMMARY: Our story picks for 1998 demonstrate a broad range of subjects. Each affects laboratories and pathology practices in significant ways and should be used to trigger appropriate management strategies. Two essential themes among this year’s ten biggest lab stories: continued d…
PPM Giant MedPartners Exits Doctor Management
By Robert Michel | From the Volume V No. 16 – November 30, 1998 Issue
THIRD IN A SERIES WHAT DOES IT MEAN WHEN the largest companies in a multibillion dollar industry announce that they will “get out” of that business? That is the question which must be answered after MedPartners, Inc. joined PhyMatrix Corp. in p…
MedPartners To Divest Hospital-Based MD Unit
By Robert Michel | From the Volume V No. 9 – July 6, 1998 Issue
CEO SUMMARY: Hospital-based pathologists are increasingly the target of buy-out offers by the emerging group of pathology based physician practice management (PPM) companies. But MedPartners decided that managing hospital-based physicians was something that was not in its best interest. W…
“May 26, 1998 Intelligence: Late Breaking Lab News”
By Robert Michel | From the Volume V No. 7 – May 26, 1998 Issue
Another pathologybased PPM received venture capital funding. Pathology Consultants of America, (PCA) based in Nashville, Tennessee, just closed a $16 million deal with two venture capitalists. ABS Capital Partners of Baltimore invested $15 million. An affiliate of …
American Path Resources Bought By Pathology PPM
By Robert Michel | From the Volume V No. 5 – April 13, 1998 Issue
CEO SUMMARY: Here is first confirmation that Pathology Consultants of America has indeed purchased American Pathology Resources. The combination of the two pathology-based physician practice management companies demonstrates that the pathology industry is on the verge of rapid transformat…
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized